Met Life Investment Management, LLC Sorrento Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

59 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 10, 2024
BUY
$0.74 - $1.83 $32,348 - $79,996
43,714 Added 21.98%
242,594 $215,000
Q4 2022

Jun 14, 2023
BUY
$0.74 - $1.83 $179,519 - $443,947
242,594 New
242,594 $215,000
Q4 2022

Mar 22, 2023
BUY
$0.74 - $1.83 $32,348 - $79,996
43,714 Added 21.98%
242,594 $215,000
Q4 2022

Feb 15, 2023
BUY
$0.74 - $1.83 $32,348 - $79,996
43,714 Added 21.98%
242,594 $215,000
Q3 2022

Jun 14, 2023
BUY
$1.51 - $2.88 $300,308 - $572,774
198,880 New
198,880 $312,000
Q2 2022

May 10, 2024
BUY
$1.24 - $2.33 $100,351 - $188,564
80,929 Added 68.61%
198,880 $399,000
Q2 2022

Jun 20, 2023
BUY
$1.24 - $2.33 $246,611 - $463,390
198,880 New
198,880 $399,000
Q2 2022

Mar 22, 2023
BUY
$1.24 - $2.33 $100,351 - $188,564
80,929 Added 68.61%
198,880 $399,000
Q2 2022

Aug 11, 2022
BUY
$1.24 - $2.33 $100,351 - $188,564
80,929 Added 68.61%
198,880 $400,000
Q1 2022

May 10, 2024
BUY
$2.0 - $4.9 $235,902 - $577,959
117,951 New
117,951 $274,000
Q1 2022

Jun 20, 2023
BUY
$2.0 - $4.9 $235,902 - $577,959
117,951 New
117,951 $274,000
Q1 2022

Mar 22, 2023
BUY
$2.0 - $4.9 $26,832 - $65,738
13,416 Added 12.83%
117,951 $274,000
Q1 2022

May 12, 2022
BUY
$2.0 - $4.9 $26,832 - $65,738
13,416 Added 12.83%
117,951 $275,000
Q4 2021

May 17, 2024
BUY
$4.65 - $7.23 $76,083 - $118,297
16,362 Added 18.56%
104,535 $486,000
Q4 2021

Jun 21, 2023
BUY
$4.65 - $7.23 $486,087 - $755,788
104,535 New
104,535 $486,000
Q4 2021

Mar 22, 2023
BUY
$4.65 - $7.23 $76,083 - $118,297
16,362 Added 18.56%
104,535 $486,000
Q4 2021

Feb 15, 2022
BUY
$4.65 - $7.23 $76,083 - $118,297
16,362 Added 18.56%
104,535 $486,000
Q3 2021

May 17, 2024
SELL
$7.41 - $10.99 $75,307 - $111,691
-10,163 Reduced 10.33%
88,173 $672,000
Q3 2021

Jun 21, 2023
BUY
$7.41 - $10.99 $653,361 - $969,021
88,173 New
88,173 $672,000
Q3 2021

Mar 22, 2023
SELL
$7.41 - $10.99 $75,307 - $111,691
-10,163 Reduced 10.33%
88,173 $672,000
Q3 2021

Nov 15, 2021
SELL
$7.41 - $10.99 $75,307 - $111,691
-10,163 Reduced 10.33%
88,173 $673,000
Q2 2021

May 17, 2024
BUY
$6.35 - $10.0 $96,818 - $152,470
15,247 Added 18.35%
98,336 $952,000
Q2 2021

Jun 21, 2023
BUY
$6.35 - $10.0 $624,433 - $983,360
98,336 New
98,336 $952,000
Q2 2021

Mar 22, 2023
BUY
$6.35 - $10.0 $96,818 - $152,470
15,247 Added 18.35%
98,336 $952,000
Q2 2021

Aug 16, 2021
BUY
$6.35 - $10.0 $96,818 - $152,470
15,247 Added 18.35%
98,336 $953,000
Q1 2021

May 17, 2024
BUY
$7.03 - $16.51 $584,115 - $1.37 Million
83,089 New
83,089 $687,000
Q1 2021

Jun 26, 2023
BUY
$7.03 - $16.51 $584,115 - $1.37 Million
83,089 New
83,089 $687 Million
Q1 2021

Mar 22, 2023
SELL
$7.03 - $16.51 $135,538 - $318,312
-19,280 Reduced 18.83%
83,089 $687,000
Q1 2021

May 14, 2021
SELL
$7.03 - $16.51 $135,538 - $318,312
-19,280 Reduced 18.83%
83,089 $687,000
Q4 2020

May 24, 2024
BUY
$5.76 - $11.95 $48,504 - $100,630
8,421 Added 8.96%
102,369 $699,000
Q4 2020

Jun 22, 2023
BUY
$5.76 - $11.95 $589,645 - $1.22 Million
102,369 New
102,369 $699,000
Q4 2020

Mar 22, 2023
BUY
$5.76 - $11.95 $48,504 - $100,630
8,421 Added 8.96%
102,369 $699,000
Q4 2020

Feb 16, 2021
BUY
$5.76 - $11.95 $48,504 - $100,630
8,421 Added 8.96%
102,369 $699,000
Q3 2020

May 24, 2024
BUY
$6.17 - $18.82 $90,544 - $276,183
14,675 Added 18.51%
93,948 $1.05 Billion
Q3 2020

Jun 26, 2023
BUY
$6.17 - $18.82 $579,659 - $1.77 Million
93,948 New
93,948 $1.05 Million
Q3 2020

Mar 22, 2023
BUY
$6.17 - $18.82 $90,544 - $276,183
14,675 Added 18.51%
93,948 $1.05 Million
Q3 2020

Nov 13, 2020
BUY
$6.17 - $18.82 $90,544 - $276,183
14,675 Added 18.51%
93,948 $1.05 Million
Q2 2020

May 24, 2024
BUY
$1.73 - $6.76 $137,142 - $535,885
79,273 New
79,273 $498 Million
Q2 2020

Jun 26, 2023
BUY
$1.73 - $6.76 $137,142 - $535,885
79,273 New
79,273 $497,000
Q2 2020

Mar 22, 2023
BUY
$1.73 - $6.76 $27,584 - $107,788
15,945 Added 25.18%
79,273 $497,000
Q2 2020

Aug 14, 2020
BUY
$1.73 - $6.76 $27,584 - $107,788
15,945 Added 25.18%
79,273 $498,000
Q1 2020

Jul 12, 2023
BUY
$1.57 - $4.76 $99,424 - $301,441
63,328 New
63,328 $116,000
Q1 2020

Mar 22, 2023
BUY
$1.57 - $4.76 $39,953 - $121,132
25,448 Added 67.18%
63,328 $116,000
Q1 2020

May 15, 2020
BUY
$1.57 - $4.76 $39,953 - $121,132
25,448 Added 67.18%
63,328 $117,000
Q4 2019

Jul 12, 2023
BUY
$1.45 - $4.17 $54,926 - $157,959
37,880 New
37,880 $128,000
Q4 2019

Mar 22, 2023
SELL
$1.45 - $4.17 $38,777 - $111,518
-26,743 Reduced 41.38%
37,880 $128,000
Q4 2019

Feb 14, 2020
SELL
$1.45 - $4.17 $38,777 - $111,518
-26,743 Reduced 41.38%
37,880 $128,000
Q3 2019

Jul 12, 2023
BUY
$2.05 - $2.69 $132,477 - $173,835
64,623 New
64,623 $138,000
Q3 2019

Mar 22, 2023
BUY
$2.05 - $2.69 $44,780 - $58,760
21,844 Added 51.06%
64,623 $138,000
Q3 2019

Nov 14, 2019
BUY
$2.05 - $2.69 $44,780 - $58,760
21,844 Added 51.06%
64,623 $138,000
Q2 2019

Jul 12, 2023
BUY
$2.67 - $4.38 $157,004 - $257,557
58,803 New
58,803 $157,000
Q1 2019

Jul 13, 2023
BUY
$1.86 - $5.94 $79,568 - $254,107
42,779 New
42,779 $203,000
Q4 2018

Jul 13, 2023
BUY
$2.01 - $4.24 $85,985 - $181,382
42,779 New
42,779 $102,000
Q4 2018

Mar 22, 2023
SELL
$2.01 - $4.24 $47,425 - $100,042
-23,595 Reduced 35.55%
42,779 $102,000
Q4 2018

Feb 14, 2019
SELL
$2.01 - $4.24 $47,425 - $100,042
-23,595 Reduced 35.55%
42,779 $103,000
Q3 2018

Jul 13, 2023
BUY
$4.22 - $7.5 $180,527 - $320,842
42,779 New
42,779 $188,000
Q3 2018

Mar 22, 2023
SELL
$4.22 - $7.5 $743,648 - $1.32 Million
-176,220 Reduced 72.64%
66,374 $292,000
Q3 2018

Nov 14, 2018
BUY
$4.22 - $7.5 $99,570 - $176,962
23,595 Added 55.16%
66,374 $292,000
Q2 2018

Aug 15, 2018
BUY
$4.75 - $8.0 $203,200 - $342,232
42,779 New
42,779 $308,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email